CNX
37
-16
MAR
72
3
CA
56
3
DHI
48
7
HPE
52
-2
PCAR
65
4
EIX
43
3
MET
50
3
SJM
28
7
LH
55
3
WMB
59
3
CMG
44
-12
HPQ
25
4
PWR
53
-9
EXR
33
3
ADP
53
5
ISRG
69
-2
LLY
80
-4
UHS
56
2
CVX
40
5
CNX
37
-16
MAR
72
3
CA
56
3
DHI
48
7
HPE
52
-2
PCAR
65
4
EIX
43
3
MET
50
3
SJM
28
7
LH
55
3
WMB
59
3
CMG
44
-12
HPQ
25
4
PWR
53
-9
EXR
33
3
ADP
53
5
ISRG
69
-2
LLY
80
-4
UHS
56
2
CVX
40
5
Financhill
Back

Invesco Bloomberg Analyst Rating Improvers ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Buy
63

UPGD
Invesco Bloomberg Analyst Rating Improvers ETF

Last Price:
$76.72
Seasonality Move:
5.42%
Buy
67

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$89.01
Seasonality Move:
-40.64%
Buy
63
Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is a Buy

Is Invesco Bloomberg Analyst Rating Improvers ETF a Buy, Sell or Hold?

  • The current Invesco Bloomberg Analyst Rating Improvers ETF [UPGD] share price is $76.19. The Score for UPGD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • UPGD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $90.01. The Score for DRUG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UPGD Stock Price Chart

What is Invesco Bloomberg Analyst Rating Improvers ETF's stock price today?

  • The Invesco Bloomberg Analyst Rating Improvers ETF share price today is $76.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPGD is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $90.01
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.

UPGD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 19.1 Buy
Relative Strength Index (14 RSI): 59.37 Buy
Chaikin Money Flow: 746 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.59 - 75.93) Buy
Bollinger Bands (100): (73.37 - 75.51) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.79 Buy
Relative Strength Index (14 RSI): 58.71 Buy
Chaikin Money Flow: -196363 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.34 - 89.1) Buy
Bollinger Bands (100): (46.01 - 75.51) Buy

UPGD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.03 Buy
20-day SMA: 75.39 Buy
50-day SMA: 74.31 Buy
200-day SMA: 72.22 Buy
8-day EMA: 72.42 Buy
20-day EMA: 54.75 Buy
50-day EMA: 30.51 Buy
200-day EMA: 9.17 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.17 Buy
20-day SMA: 84.39 Buy
50-day SMA: 70.26 Buy
200-day SMA: 45.73 Buy
8-day EMA: 86.85 Buy
20-day EMA: 82.54 Buy
50-day EMA: 73.48 Buy
200-day EMA: 51.43 Buy

Invesco Bloomberg Analyst Rating Improvers ETF Earnings Growth & UPGD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.03 per share, and a decrease next year of $3.86 per share.

Invesco Bloomberg Analyst Rating Improvers ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):